Wnt pathway modulating peptide (hair research)
Wnt pathway peptide
A peptide studied preclinically to reactivate hair follicle Wnt signaling; human clinical evidence is absent.
- Evidence:
- Preclinical evidence primarily
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: Wnt pathway peptide, CXXC5 inhibitor peptide
What is Wnt pathway peptide?
A peptide studied preclinically to reactivate hair follicle Wnt signaling; human clinical evidence is absent.
This profile is educational. It organizes publicly discussed research context for Wnt pathway peptide and related naming aliases — it is not a treatment guide.
Proposed mechanism
Disrupts CXXC5 interaction with Dishevelled, releasing Wnt/β-catenin signaling in follicle stem cells to promote anagen.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Preclinical evidence primarily
Preclinical evidence grade: Early-stage human research
PTD-DBM showed hair regrowth in mouse models by activating Wnt pathways. Developed by Korean researchers. Human trials are limited or unpublished. Represents investigational hair biology research. Not FDA approved.
Key uncertainties
- Translation to human hair loss
- Combination with existing therapies
Research areas being studied
- Androgenetic alopecia
- Wnt signaling
- Follicle stem cells
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Not established in humans
Additional risks & considerations
- No human safety data
- Unregulated research products
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Wnt pathway peptide?
A peptide studied preclinically to reactivate hair follicle Wnt signaling; human clinical evidence is absent.
How does Wnt pathway peptide work (proposed mechanism)?
Disrupts CXXC5 interaction with Dishevelled, releasing Wnt/β-catenin signaling in follicle stem cells to promote anagen.
What is Wnt pathway peptide being researched for?
Wnt pathway peptide has been discussed in research contexts including: Androgenetic alopecia, Wnt signaling, Follicle stem cells.
What does current evidence say about Wnt pathway peptide?
Preclinical evidence primarily. PTD-DBM showed hair regrowth in mouse models by activating Wnt pathways. Developed by Korean researchers. Human trials are limited or unpublished. Represents investigational hair biology research. Not FDA approved.
What safety considerations are noted for Wnt pathway peptide?
Reported or discussed considerations include: Not established in humans; No human safety data; Unregulated research products. This is educational information, not medical advice.
References & sources
- Lee SH et al. (2017). CXXC5 peptide therapy for hair regrowth via Wnt activation — J Invest Dermatol. Evidence type: animal.
Prefer interactive tools? Open the PepGuide library entry for Wnt pathway peptide or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.